Additionally, the expression of IL-6, IL-12p70, CCL2 and TNF in the Parp1−/− model group was markedly reduced and IL-10 increased significantly compared to that in the WT model group, suggesting that PARP1 enhanced the inflammatory factors secretion in prostatitis. Here, PARP1 is linked to urogenital neoplasm.